Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2016020324) MULTI-COMPONENT CRYSTALS OF VISMODEGIB AND SELECTED CO-CRYSTAL FORMERS OR SOLVENTS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2016/020324 International Application No.: PCT/EP2015/067822
Publication Date: 11.02.2016 International Filing Date: 03.08.2015
IPC:
C07D 213/40 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
213
Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
02
having three double bonds between ring members or between ring members and non-ring members
04
having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
24
with substituted hydrocarbon radicals attached to ring carbon atoms
36
Radicals substituted by singly-bound nitrogen atoms
40
Acylated substituent nitrogen atom
Applicants:
BASF SE [DE/DE]; 67056 Ludwigshafen, DE
Inventors:
VIERTELHAUS, Martin; DE
CHIODO, Tiziana; DE
SALVADOR, Beate; DE
VOSSEN, Marcus; DE
HAFNER, Andreas; CH
HINTERMANN, Tobias; CH
WEISHAAR, Walter; DE
HELLMANN, Rolf; DE
Agent:
UPSCHULTE, Manfred; CH
Priority Data:
14180255.307.08.2014EP
Title (EN) MULTI-COMPONENT CRYSTALS OF VISMODEGIB AND SELECTED CO-CRYSTAL FORMERS OR SOLVENTS
(FR) CRISTAUX MULTICOMPOSANTS DE VISMODEGIB ET AGENTS DE FORMATION DE CO-CRISTAUX OU SOLVANTS SÉLECTIONNÉS
Abstract:
(EN) The present invention primarily relates to multi-component crystals comprising a compound of formula 1 and a second compound selected from the group consisting of co-crystal formers and sol-vents. The invention is further related to pharmaceutical compositions comprising such multi-component crystals. Furthermore, the invention relates to processes for preparing said multi-component crystals. The invention also relates to several aspects of using said multi-component crystals or pharmaceutical compositions to treat a disease.
(FR) L'invention concerne principalement des cristaux multicomposants comprenant un composé de formule 1 et un second composé choisi dans le groupe constitué d'agents de formation de co-cristaux et de solvants. Elle concerne également des compositions pharmaceutiques contenant lesdits cristaux multicomposants. Elle concerne en outre des méthodes de préparation desdits cristaux multicomposants. L'invention concerne aussi plusieurs aspects d'utilisation desdits cristaux multicomposants ou de compositions pharmaceutiques pour traiter une maladie.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
CN106573888CA2955570US20170216266JP2017524004IN201727007261